Integrated BioTherapeutics
- PMID: 29641293
- PMCID: PMC6037449
- DOI: 10.1080/21645515.2018.1440105
Integrated BioTherapeutics
References
-
- Chen WH, Pasetti MF, Adhikari RP, Baughman H, Douglas R, El-Khorazaty J, Greenberg N, Holtsberg FW, Liao GC, Reymann MK, et al.. Safety and immunogenicity of a parenterally administered, structure-based rationally modified recombinant staphylococcal enterotoxin B Protein Vaccine, STEBVax. Clin Vaccine Immunol. 2016;23:918–925 doi:10.1128/CVI.00399-16. PMID:27707765. - DOI - PMC - PubMed
-
- Adhikari RP, Karauzum H, Sarwar J, Abaandou L, Mahmoudieh M, Boroun AR, Vu H, Nguyen T, Devi VS, Shulenin S, et al.. Novel structurally designed vaccine for S. aureus alpha-Hemolysin: Protection against bacteremia and pneumonia. PLoS One. 2012;7:e38567 doi:10.1371/journal.pone.0038567. PMID:22701668. - DOI - PMC - PubMed
-
- Karauzum H, Adhikari RP, Sarwar J, Devi VS, Abaandou L, Haudenschild C, Mahmoudieh M, Boroun AR, Vu H, Nguyen T, et al.. Structurally designed attenuated subunit Vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model. PLoS One. 2013;8:e65384 doi:10.1371/journal.pone.0065384. PMID:23762356. - DOI - PMC - PubMed
-
- Howell KA, Qiu X, Brannan JM, Bryan C, Davidson E, Holtsberg FW, Wec AZ, Shulenin S, Biggins JE, Douglas R, et al.. Antibody treatment of ebola and sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site. Cell Rep. 2016;15:1514–26 doi:10.1016/j.celrep.2016.04.026. PMID:27160900. - DOI - PMC - PubMed
-
- Zhao X, Howell KA, He S, Brannan JM, Wec AZ, Davidson E, Turner HL, Chiang CI, Lei L, Fels JM, et al.. Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability. Cell. 2017;169:891–904 e15 doi:10.1016/j.cell.2017.04.038. PMID:28525756. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical